Loading…

Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene

Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We all...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1997-03, Vol.57 (6), p.1039-1042
Main Authors: DEBELENKO, L. V, EMMERT-BUCK, M. R, BURNS, A. L, SPIEGEL, A. M, LIOTTA, L. A, COLLINS, F. S, MARX, S. J, CHANDRASEKHARAPPA, S. C, MANICKAM, P, KESTER, M, GURU, S. C, DIFRANCO, E. M, OLUFEMI, S.-E, AGARWAL, S, LUBENSKY, I. A, ZHUANG, Z
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1042
container_issue 6
container_start_page 1039
container_title Cancer research (Chicago, Ill.)
container_volume 57
creator DEBELENKO, L. V
EMMERT-BUCK, M. R
BURNS, A. L
SPIEGEL, A. M
LIOTTA, L. A
COLLINS, F. S
MARX, S. J
CHANDRASEKHARAPPA, S. C
MANICKAM, P
KESTER, M
GURU, S. C
DIFRANCO, E. M
OLUFEMI, S.-E
AGARWAL, S
LUBENSKY, I. A
ZHUANG, Z
description Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78886698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16442462</sourcerecordid><originalsourceid>FETCH-LOGICAL-h299t-c06f38e35724b5c063bda2c7e19edc1da74756007201bf58b86028fef2f924043</originalsourceid><addsrcrecordid>eNqFkE9LxDAUxIMo67r6EYQcRPRQSNL861GW1RVWvei5pO2LG0nT2rTCfnuDFq-e3gzzY3jMEVpSketMcS6O0ZIQojPBFTtFZzF-JCsoEQu0KIhUTMolgq3pfTceesAmGH-ILuIGrAsQscGtC641HrswwvCVhO0GPO4Bt5MfXe8BQ2i6ekg4DtD13kRn8E8bxTdPm2d6i98hwDk6scZHuJjvCr3db17X22z38vC4vttle1YUY1YTaXMNuVCMVyK5vGoMqxXQApqaNkZxJSQhihFaWaErLQnTFiyzBeOE5yt0_dvbD93nBHEsWxdr8N6k76ZYKq21lIX-F6SSc8YlS-DlDE5VC03ZD2mQ4VDOA6b8as5NrI23gwm1i38Yk5RowfJvq9l5Tw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16442462</pqid></control><display><type>article</type><title>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>DEBELENKO, L. V ; EMMERT-BUCK, M. R ; BURNS, A. L ; SPIEGEL, A. M ; LIOTTA, L. A ; COLLINS, F. S ; MARX, S. J ; CHANDRASEKHARAPPA, S. C ; MANICKAM, P ; KESTER, M ; GURU, S. C ; DIFRANCO, E. M ; OLUFEMI, S.-E ; AGARWAL, S ; LUBENSKY, I. A ; ZHUANG, Z</creator><creatorcontrib>DEBELENKO, L. V ; EMMERT-BUCK, M. R ; BURNS, A. L ; SPIEGEL, A. M ; LIOTTA, L. A ; COLLINS, F. S ; MARX, S. J ; CHANDRASEKHARAPPA, S. C ; MANICKAM, P ; KESTER, M ; GURU, S. C ; DIFRANCO, E. M ; OLUFEMI, S.-E ; AGARWAL, S ; LUBENSKY, I. A ; ZHUANG, Z</creatorcontrib><description>Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 9067266</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Alleles ; Biological and medical sciences ; Chromosome Mapping ; Chromosomes, Human, Pair 11 - genetics ; DNA, Neoplasm - genetics ; Endocrinopathies ; Female ; General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes ; Genetic Markers ; Haplotypes - genetics ; Humans ; Male ; Medical sciences ; Multiple Endocrine Neoplasia Type 1 - genetics ; Pedigree ; Polymorphism, Genetic ; Recombination, Genetic</subject><ispartof>Cancer research (Chicago, Ill.), 1997-03, Vol.57 (6), p.1039-1042</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2610852$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9067266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DEBELENKO, L. V</creatorcontrib><creatorcontrib>EMMERT-BUCK, M. R</creatorcontrib><creatorcontrib>BURNS, A. L</creatorcontrib><creatorcontrib>SPIEGEL, A. M</creatorcontrib><creatorcontrib>LIOTTA, L. A</creatorcontrib><creatorcontrib>COLLINS, F. S</creatorcontrib><creatorcontrib>MARX, S. J</creatorcontrib><creatorcontrib>CHANDRASEKHARAPPA, S. C</creatorcontrib><creatorcontrib>MANICKAM, P</creatorcontrib><creatorcontrib>KESTER, M</creatorcontrib><creatorcontrib>GURU, S. C</creatorcontrib><creatorcontrib>DIFRANCO, E. M</creatorcontrib><creatorcontrib>OLUFEMI, S.-E</creatorcontrib><creatorcontrib>AGARWAL, S</creatorcontrib><creatorcontrib>LUBENSKY, I. A</creatorcontrib><creatorcontrib>ZHUANG, Z</creatorcontrib><title>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.</description><subject>Alleles</subject><subject>Biological and medical sciences</subject><subject>Chromosome Mapping</subject><subject>Chromosomes, Human, Pair 11 - genetics</subject><subject>DNA, Neoplasm - genetics</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes</subject><subject>Genetic Markers</subject><subject>Haplotypes - genetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multiple Endocrine Neoplasia Type 1 - genetics</subject><subject>Pedigree</subject><subject>Polymorphism, Genetic</subject><subject>Recombination, Genetic</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LxDAUxIMo67r6EYQcRPRQSNL861GW1RVWvei5pO2LG0nT2rTCfnuDFq-e3gzzY3jMEVpSketMcS6O0ZIQojPBFTtFZzF-JCsoEQu0KIhUTMolgq3pfTceesAmGH-ILuIGrAsQscGtC641HrswwvCVhO0GPO4Bt5MfXe8BQ2i6ekg4DtD13kRn8E8bxTdPm2d6i98hwDk6scZHuJjvCr3db17X22z38vC4vttle1YUY1YTaXMNuVCMVyK5vGoMqxXQApqaNkZxJSQhihFaWaErLQnTFiyzBeOE5yt0_dvbD93nBHEsWxdr8N6k76ZYKq21lIX-F6SSc8YlS-DlDE5VC03ZD2mQ4VDOA6b8as5NrI23gwm1i38Yk5RowfJvq9l5Tw</recordid><startdate>19970315</startdate><enddate>19970315</enddate><creator>DEBELENKO, L. V</creator><creator>EMMERT-BUCK, M. R</creator><creator>BURNS, A. L</creator><creator>SPIEGEL, A. M</creator><creator>LIOTTA, L. A</creator><creator>COLLINS, F. S</creator><creator>MARX, S. J</creator><creator>CHANDRASEKHARAPPA, S. C</creator><creator>MANICKAM, P</creator><creator>KESTER, M</creator><creator>GURU, S. C</creator><creator>DIFRANCO, E. M</creator><creator>OLUFEMI, S.-E</creator><creator>AGARWAL, S</creator><creator>LUBENSKY, I. A</creator><creator>ZHUANG, Z</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19970315</creationdate><title>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</title><author>DEBELENKO, L. V ; EMMERT-BUCK, M. R ; BURNS, A. L ; SPIEGEL, A. M ; LIOTTA, L. A ; COLLINS, F. S ; MARX, S. J ; CHANDRASEKHARAPPA, S. C ; MANICKAM, P ; KESTER, M ; GURU, S. C ; DIFRANCO, E. M ; OLUFEMI, S.-E ; AGARWAL, S ; LUBENSKY, I. A ; ZHUANG, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h299t-c06f38e35724b5c063bda2c7e19edc1da74756007201bf58b86028fef2f924043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Alleles</topic><topic>Biological and medical sciences</topic><topic>Chromosome Mapping</topic><topic>Chromosomes, Human, Pair 11 - genetics</topic><topic>DNA, Neoplasm - genetics</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes</topic><topic>Genetic Markers</topic><topic>Haplotypes - genetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multiple Endocrine Neoplasia Type 1 - genetics</topic><topic>Pedigree</topic><topic>Polymorphism, Genetic</topic><topic>Recombination, Genetic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DEBELENKO, L. V</creatorcontrib><creatorcontrib>EMMERT-BUCK, M. R</creatorcontrib><creatorcontrib>BURNS, A. L</creatorcontrib><creatorcontrib>SPIEGEL, A. M</creatorcontrib><creatorcontrib>LIOTTA, L. A</creatorcontrib><creatorcontrib>COLLINS, F. S</creatorcontrib><creatorcontrib>MARX, S. J</creatorcontrib><creatorcontrib>CHANDRASEKHARAPPA, S. C</creatorcontrib><creatorcontrib>MANICKAM, P</creatorcontrib><creatorcontrib>KESTER, M</creatorcontrib><creatorcontrib>GURU, S. C</creatorcontrib><creatorcontrib>DIFRANCO, E. M</creatorcontrib><creatorcontrib>OLUFEMI, S.-E</creatorcontrib><creatorcontrib>AGARWAL, S</creatorcontrib><creatorcontrib>LUBENSKY, I. A</creatorcontrib><creatorcontrib>ZHUANG, Z</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DEBELENKO, L. V</au><au>EMMERT-BUCK, M. R</au><au>BURNS, A. L</au><au>SPIEGEL, A. M</au><au>LIOTTA, L. A</au><au>COLLINS, F. S</au><au>MARX, S. J</au><au>CHANDRASEKHARAPPA, S. C</au><au>MANICKAM, P</au><au>KESTER, M</au><au>GURU, S. C</au><au>DIFRANCO, E. M</au><au>OLUFEMI, S.-E</au><au>AGARWAL, S</au><au>LUBENSKY, I. A</au><au>ZHUANG, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1997-03-15</date><risdate>1997</risdate><volume>57</volume><issue>6</issue><spage>1039</spage><epage>1042</epage><pages>1039-1042</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>9067266</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1997-03, Vol.57 (6), p.1039-1042
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_78886698
source Free E-Journal (出版社公開部分のみ)
subjects Alleles
Biological and medical sciences
Chromosome Mapping
Chromosomes, Human, Pair 11 - genetics
DNA, Neoplasm - genetics
Endocrinopathies
Female
General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes
Genetic Markers
Haplotypes - genetics
Humans
Male
Medical sciences
Multiple Endocrine Neoplasia Type 1 - genetics
Pedigree
Polymorphism, Genetic
Recombination, Genetic
title Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A42%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haplotype%20analysis%20defines%20a%20minimal%20interval%20for%20the%20multiple%20endocrine%20neoplasia%20type%201%20(MEN1)%20gene&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=DEBELENKO,%20L.%20V&rft.date=1997-03-15&rft.volume=57&rft.issue=6&rft.spage=1039&rft.epage=1042&rft.pages=1039-1042&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E16442462%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h299t-c06f38e35724b5c063bda2c7e19edc1da74756007201bf58b86028fef2f924043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16442462&rft_id=info:pmid/9067266&rfr_iscdi=true